Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT

Clinical trial NCT04764513 · UNKNOWN

Trial details

NCT number: NCT04764513
Sponsor: Chinese PLA General Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndromes Lymphoma

Start date: 2021-09-12
Primary completion: 2023-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.